Lei Wei
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Cancer-related gene regulation
- Natural product bioactivities and synthesis
Papers in
-
- RNA modifications and cancer 15
- Circular RNAs in diseases 12
- RNA Research and Splicing 6
- Cancer-related gene regulation 5
- Wnt/β-catenin signaling in development and cancer 5
-
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 10
- Co-authors
- Yang Gao (19 shared papers)Jingwei Zhang (18 shared papers)Xiaolong Xu (18 shared papers)Yihao Tian (20 shared papers)Chunjiang He (4 shared papers)Ke Chen (3 shared papers)Xiaoning Yuan (11 shared papers)Weinan Yin (7 shared papers)
- Journals
- European Journal of Pharmacology (4 papers)Frontiers in Genetics (3 papers)Oncogene (3 papers)Frontiers in Oncology (3 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Lei Wei
107 papers receiving 2.6k citations
Lei Wei's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.0k
- Molecular Biology 1.8k
- Pharmacology 108
- Applied Microbiology and Biotechnology 16
- Oncology 204
Countries citing papers authored by Lei Wei
This map shows the geographic impact of Lei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wei more than expected).
Fields of papers citing papers by Lei Wei
This network shows the impact of papers produced by Lei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wei. The network helps show where Lei Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 317 | |
| 2 | CircRNA inhibits DNA damage repair by interacting with host gene Hit paper breakdown → | 2020 | 294 |
| 3 | 2018 | 115 | |
| 4 | 2020 | 89 | |
| 5 | 2018 | 82 | |
| 6 | 2007 | 73 | |
| 7 | 2013 | 64 | |
| 8 | 2010 | 61 | |
| 9 | 2011 | 52 | |
| 10 | 2009 | 51 | |
| 11 | 2015 | 48 | |
| 12 | 2004 | 48 | |
| 13 | 2020 | 47 | |
| 14 | 2014 | 42 | |
| 15 | 2019 | 37 | |
| 16 | 2021 | 36 | |
| 17 | 2019 | 35 | |
| 18 | 2018 | 32 | |
| 19 | 2016 | 32 | |
| 20 | 2020 | 30 |
About Lei Wei
Lei Wei is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 113 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (15 papers), Circular RNAs in diseases (12 papers), MicroRNA in disease regulation (10 papers), Cancer-related Molecular Pathways (8 papers), RNA Research and Splicing (6 papers), Cancer-related gene regulation (5 papers) and Wnt/β-catenin signaling in development and cancer (5 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.8k citations), Pharmacology (108 citations), Applied Microbiology and Biotechnology (16 citations) and Oncology (204 citations). Lei Wei has collaborated with scholars based in China, United States and France. Frequent co-authors include Yang Gao, Jingwei Zhang, Xiaolong Xu, Yihao Tian, Chunjiang He, Ke Chen, Xiaoning Yuan, Weinan Yin, Pengchao Hu and Ke Su. Their work appears in journals such as European Journal of Pharmacology, Frontiers in Genetics, Oncogene, Frontiers in Oncology and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.